NEW YORK (GenomeWeb) – Plant genome engineering firm Calyxt yesterday announced it has signed an exclusive license agreement with the University of Minnesota for worldwide rights to intellectual property for gene targeting.

Calyxt now has rights to a family of patents entitled "Gene Targeting in Plants Using DNA Viruses." The technology is based on a group of DNA viruses known as geminiviruses and enables efficient targeted modification of plant genomes in conjunction with customizable endonucleases, the firm said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.